This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Dalhousie University directory, so their courses may be missing. Find their university profile.
Research
Latest papers
A controlled human infection model for symptomatic pertussis in North America using the pertactin-producing clinical isolate D420.
medRxiv : the preprint server for health sciences · 2026
The amorphization of crystalline silicon by ball milling.
Heliyon · 2024
Mast cells selectively produce inflammatory mediators and impact the early response to Chlamydia reproductive tract infection.
Frontiers in immunology · 2023
Latest funding
- $4,569,190
Open-label, phase 1/2, dose-escalation and dose-confirmation clinical trial to establish a Controlled Human Infection Model (CHIM) by determining and confirming the optimal, safe, and reproducible Influenza A:H3N2 dose administered intranasally to healthy adults 18-40 years of age that induces mild symptomatic infection and detection of Influenza A:H3N2 in nasal secretions by culture and/or PCR
CIHR · 2023 · Co-investigator
- $150,000
Understanding the role of chronic chlamydial infection in ovarian cancer
CIHR · 2023 · Nominated PI
- $1,142,297
Open-label, phase 1/2, dose-escalation and dose-confirmation clinical trial to establish a Controlled Human Infection Model (CHIM) by determining and confirming the optimal, safe, and reproducible Influenza A:H3N2 dose administered intranasally to healthy adults 18-40 years of age that induces mild symptomatic infection and detection of Influenza A:H3N2 in nasal secretions by culture and/or PCR
CIHR · 2023 · Co-investigator
22 publications.
A controlled human infection model for symptomatic pertussis in North America using the pertactin-producing clinical isolate D420.
ElSherif MS, Redden KL, Langley JM, Ye L, Blanchard W, Smith B, Wang J, Abu-Raya B, Filliter JH, Edwards KM, Creech CB, McNeil S, Hatchette TF, LeBlanc JJ, Hariri S, Pawloski L, Maniatis P, Fox LM, Whittle CA, Halperin SA
The amorphization of crystalline silicon by ball milling.
Gauthier R, Scott B, Bennett JC, Salehabadi M, Wang J, Sainuddin T, Obrovac MN
Mast cells selectively produce inflammatory mediators and impact the early response to Chlamydia reproductive tract infection.
Mayavannan A, Shantz E, Haidl ID, Wang J, Marshall JS
Editorial: Cytokine and cytokine receptor-based immunotherapies: Updates, controversies, challenges, and future perspectives.
Wang J, Johnston B, Berraondo P
New insights into Chlamydia pathogenesis: Role of leukemia inhibitory factor.
Wang J, Wang K
Mitochondrial damage-associated molecular patterns trigger arginase-dependent lymphocyte immunoregulation.
Westhaver LP, Nersesian S, Nelson A, MacLean LK, Carter EB, Rowter D, Wang J, Gala-Lopez BL, Stadnyk AW, Johnston B, Boudreau JE
Corrigendum: Multi-Source Pathways of T Follicular Helper Cell Differentiation.
Ma X, Nakayamada S, Wang J
Myeloid-derived suppressor cell depletion therapy targets IL-17A-expressing mammary carcinomas.
Dawod B, Liu J, Gebremeskel S, Yan C, Sappong A, Johnston B, Hoskin DW, Marshall JS, Wang J
The lysosomal TRPML1 channel regulates triple negative breast cancer development by promoting mTORC1 and purinergic signaling pathways.
Xu M, Almasi S, Yang Y, Yan C, Sterea AM, Rizvi Syeda AK, Shen B, Richard Derek C, Huang P, Gujar S, Wang J, Zong WX, Trebak M, El Hiani Y, Dong XP
Corrigendum: Confinement of Suspension-Cultured Cells in Polyethylene Glycol/Polyethylene Oxide-Albumin Aqueous Two-Phase Systems.
Teixeira AG, Kleinman A, Agarwal R, Tam NW, Wang J, Frampton JP
Open-label, phase 1/2, dose-escalation and dose-confirmation clinical trial to establish a Controlled Human Infection Model (CHIM) by determining and confirming the optimal, safe, and reproducible Influenza A:H3N2 dose administered intranasally to healthy adults 18-40 years of age that induces mild symptomatic infection and detection of Influenza A:H3N2 in nasal secretions by culture and/or PCR
Principal investigators: Halperin, Scott A; Ward, Brian J
Keywords: Challenge Study; Challenge Unit; Controlled Human Infection Model (Chim); Dose-Finding; Dose-Ranging; Healthy Adults; Influenza Virus; Pandemic Preparedness; Phase 1/2 Clinical Trial
Understanding the role of chronic chlamydial infection in ovarian cancer
Principal investigators: Wang, Jun
Keywords: Chlamydia Infection; Epithelial Mesenchymal Transition (Emt); Genetically Engineered Hgsc Mouse Model; High-Grade Serous Ovarian Carcinoma (Hgsc); Ovarian Cancer; Tumor-Specific Microenvironment (Tme)
Open-label, phase 1/2, dose-escalation and dose-confirmation clinical trial to establish a Controlled Human Infection Model (CHIM) by determining and confirming the optimal, safe, and reproducible Influenza A:H3N2 dose administered intranasally to healthy adults 18-40 years of age that induces mild symptomatic infection and detection of Influenza A:H3N2 in nasal secretions by culture and/or PCR
Principal investigators: Halperin, Scott A; Ward, Brian J
Keywords: Challenge Study; Challenge Unit; Controlled Human Infection Model (Chim); Dose-Finding; Dose-Ranging; Healthy Adults; Influenza Virus; Pandemic Preparedness; Phase 1/2 Clinical Trial
A phase 2 trial to evaluate safety and immunogenicity of a next-generation COVID-19 vaccine delivered by inhaled aerosol to humans
Principal investigators: Smaill, Fiona M; Comeau, Jeannette L; Gauvreau, Gail M; Halperin, Scott A; Langley, Joanne M; Loeb, Mark B; Miller, Matthew S; Satia, Imran; Wang, Jun; Xing, Zhou
Keywords: Adenoviral-Vectored; Antibody & T Cell Immunity; Clinical Trial; Covid-19; Inhaled Aerosol; Mucosal Immunization; Next-Generation Vaccine; Respiratory Mucosal Immunity; Sars-Cov2; Trained Innate Immunity
A phase 2 trial to evaluate safety and immunogenicity of a next-generation COVID-19 vaccine delivered by inhaled aerosol to humans
Principal investigators: Smaill, Fiona M; Comeau, Jeannette L; Gauvreau, Gail M; Halperin, Scott A; Langley, Joanne M; Loeb, Mark B; Miller, Matthew S; Satia, Imran; Wang, Jun; Xing, Zhou
Keywords: Adenoviral-Vectored; Antibody & T Cell Immunity; Clinical Trial; Covid-19; Inhaled Aerosol; Mucosal Immunization; Next-Generation Vaccine; Respiratory Mucosal Immunity; Sars-Cov2; Trained Innate Immunity
Defining critical pathways of innate immunity for precision therapy of autoimmune diseases
Principal investigators: Issekutz, Thomas B; Huber, Adam M; Barsalou, Julie; Boudreau, Jeanette E; Derfalvi, Beata; Haddad, Elie; Hanly, John G; Johnston, Brent; Kelvin, David J; Marshall, Jean S; Ritz, Stacey A; Touzot, Fabien; Turvey, Stuart E; Wang, Jun
Keywords: Arthritis; Human Immunology; Immunogenetics; Innate Immunity; Interferons; Lupus
Investigating the role of repeated low-dose infections in Chlamydia pathogenesis.
Principal investigators: Wang, Jun
Keywords: Animal Model; Cd4 T Helper; Cellular Immunity, Antibody; Chlamydia; Immunopathology; Infection; Innate-Like B1 Cells; Regulatory T Cells; Sti; Th1, Th17, Tfh
Regulatory B cell development
Principal investigators: Wang, Jun
Canadian Immunization Research Network
Principal investigators: Halperin, Scott A; Andrew, Melissa K; Bettinger, Julie A; Bolotin, Shelly; Brisson, Marc; Coleman, Brenda L; Crowcroft, Natasha S; De Serres, Gaston; De Wals, Philippe; Deeks, Shelley L; Dubé, Eve; Fisman, David N; Hatchette, Todd F; Isenor, Jennifer; Kwong, Jeffrey C; Langley, Joanne M; Loeb, Mark B; MacDougall, Heather A; Mahmud, Salaheddin; McNeil, Shelly A; Naus, Monika; Ogilvie, Gina S; Quach-Thanh, Caroline; Scheifele, David W; Top, Karina A; Van Buynder, Paul; Vaudry, Wendy L; Ward, Brian J; Watts, Tania H; Wilson, Kumanan; Wilson, Sarah
Keywords: Adverse Events Following Immunization; Immunogenicity; Population-Based Methodology; Rapid Response Research Capacity; Vaccine Coverage; Vaccine Effectiveness; Vaccine Hesitancy; Vaccine Safety; Vulnerable Populations
IL-17RA and IL-17RC signaling in hematopoietic and non-hematopoietic cells
Principal investigators: Wang, Jun
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Tong-Jun Lin and Zhenyu Cheng: 3 shared papers
- Brent Johnston and Jun Wang: 3 shared papers
- Zhou Xing and Jun Wang: 2 shared papers
- Scott Halperin and Shelly McNeil: 2 shared papers
- Tong-Jun Lin and Brent Johnston: 2 shared papers
- Brent Johnston and Zhenyu Cheng: 2 shared papers
- Zhou Xing and Scott Halperin: 1 shared paper
- Matthew Brace and Jun Wang: 1 shared paper
- Scott Halperin and Jun Wang: 1 shared paper
- Shelly McNeil and Jun Wang: 1 shared paper
- Shelly McNeil and Bahaa Abu-Raya: 1 shared paper
- Tong-Jun Lin and Jun Wang: 1 shared paper
- Jeanette Boudreau and Jun Wang: 1 shared paper
- Jeanette Boudreau and Zhenyu Cheng: 1 shared paper
- Jun Wang and Zhenyu Cheng: 1 shared paper
- Jun Wang and Shashi Gujar: 1 shared paper
- Jun Wang and Bahaa Abu-Raya: 1 shared paper
- Zhenyu Cheng and Shashi Gujar: 1 shared paper
- Microbiology and Immunology
- Pediatrics
- Medicine
- Surgery
- Pathology
Co-authors at Dalhousie University, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Brent Johnston
Pediatrics
3 shared papers, latest 2022
Zhou Xing
Medicine
2 shared papers, latest 2016
Zhenyu Cheng
Microbiology and Immunology
1 shared papers, latest 2019
Shashi Gujar
Pathology
1 shared papers, latest 2019
Bahaa Abu-Raya
Pediatrics
1 shared papers, latest 2026
Scott Halperin
Pediatrics
1 shared papers, latest 2009
Tong-Jun Lin
Microbiology and Immunology
1 shared papers, latest 2017
Jeanette Boudreau
Microbiology and Immunology
1 shared papers, latest 2019
Shelly McNeil
Pediatrics
1 shared papers, latest 2026
Matthew Brace
Surgery
1 shared papers, latest 2014
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.